Filing Flows › Verastem (VSTM) › Q3 2025
Verastem (VSTM) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 4, 2025
Verastem (VSTM) reported revenue of $11.2M for the third quarter 2025 (Q3 2025) and +426% from the quarter before. Operating margin was -362.2%, net loss $98.5M (876.3% of revenue).
Verastem, Q3 2025: revenue $11.2M, operating margin -362.2%, net loss $98.5M, operating cash flow −$36.2M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.2M | +426% | — |
| Operating profit | −$40.7M | — | — |
| Net earnings | −$98.5M | — | — |
| Operating cash flow | −$36.2M | — | — |
What changed
Revenue was $11.2M in Q3 2025, up 426% from the previous quarter.
Operating costs exceeded revenue by $40.7M, an operating margin of -362.2%. The quarter ended with a net loss of $98.5M, wider than the previous quarter's $25.9M loss. Net interest and other expense of $57.8M was the main reason.
Operating cash flow was −$36.2M. Non-cash charges added back $292K of depreciation and amortization and $2.2M of share-based compensation. Working capital and other items added $59.8M.
Questions
What was Verastem's revenue in the third quarter 2025?
Verastem (VSTM) reported revenue of $11.2M for the third quarter 2025 (Q3 2025) and +426% from the quarter before.
Was Verastem profitable in the third quarter 2025?
Operating loss was $40.7M (-362.2% of revenue) and net loss $98.5M.
Source: Verastem 10-Q on SEC EDGAR.